Verona Pharma (VRNA) Earnings Date, Estimates & Call Transcripts $63.36 -2.90 (-4.38%) As of 05/9/2025 03:59 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Verona Pharma Earnings Summary Verona Pharma released Q1 2025 earnings on April 29, 2025, reporting an EPS of $0.27, which beat analysts' consensus estimates of -$0.22 by $0.49. Quarterly revenue was reported to be $98.65 million, above the consensus estimate of $41.47 million. With a trailing EPS of -$2.00, Verona Pharma's earnings are expected to grow next year, from ($1.95) to $0.03 per share. Latest Q1 Earnings DateApr. 29EstimatedConsensus EPS (Apr. 29) -$0.22 Actual EPS (Apr. 29) $0.27 Beat By $0.49 Actual Revenue (Apr. 29) $98.65MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingPowered by Get Verona Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Verona Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataVRNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VRNA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Verona Pharma Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251-$0.24-$0.24-$0.24Q2 20252-$0.16-$0.08-$0.12Q3 20252$0.08$0.13$0.11Q4 20252$0.02$0.36$0.19 FY 2025 7 -$0.30 $0.17 -$0.07 Q1 20262$0.40$0.68$0.54Q2 20262$0.64$0.91$0.78Q3 20262$0.88$1.02$0.95Q4 20261$1.18$1.18$1.18 Verona Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails4/29/2025Q1 2025-$0.22$0.27+$0.49-$0.16$41.47M$98.65M11/4/2024Q3 2024-$0.44-$0.56 -$0.12-$0.56$2.31M$5.62M8/8/2024Q2 2024-$0.35-$0.88 -$0.53-$0.88--5/9/2024Q1 2024-$0.24-$0.32 -$0.08-$0.32--2/29/2024Q4 2023-$0.23-$0.16+$0.07-$0.16--11/2/2023Q3 2023-$0.27-$0.18+$0.09-$0.18--8/3/2023Q2 2023-$0.27-$0.11+$0.16-$0.11-- Verona Pharma Earnings - Frequently Asked Questions When did Verona Pharma announce their last quarterly earnings? Verona Pharma (NASDAQ:VRNA) last announced its quarterly earning data on Tuesday, April 29, 2025. Learn more on VRNA's earnings history. Did Verona Pharma beat their earnings estimates last quarter? In the previous quarter, Verona Pharma (NASDAQ:VRNA) reported $0.27 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.22) by $0.49. Learn more on analysts' earnings estimate vs. VRNA's actual earnings. How can I listen to Verona Pharma's earnings conference call? The conference call for Verona Pharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Verona Pharma's conference call transcript? The conference call transcript for Verona Pharma's latest earnings report can be read online. Read Transcript How can I view Verona Pharma's earnings report? Verona Pharma's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Verona Pharma generate each year? Verona Pharma (NASDAQ:VRNA) has a recorded annual revenue of $118.54 million. How much profit does Verona Pharma generate each year? Verona Pharma (NASDAQ:VRNA) has a recorded net income of -$54.37 million. VRNA has generated -$2.00 earnings per share over the last four quarters. What is Verona Pharma's EPS forecast for next year? Verona Pharma's earnings are expected to grow from ($1.95) per share to $0.03 per share in the next year. More Earnings Resources from MarketBeat Related Companies SMMT Earnings Results TEVA Earnings Results ITCI Earnings Results GMAB Earnings Results RDY Earnings Results MRNA Earnings Results ASND Earnings Results VTRS Earnings Results QGEN Earnings Results ROIV Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming?DexCom Stock: Earnings Beat and New Market Access Drive Bull CaseDisney Stock Jumps on Earnings—Is the Magic Sustainable? This page (NASDAQ:VRNA) was last updated on 5/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Remember when they said crypto would never go mainstream? Well, something remarkable has happened… Blac...Crypto 101 Media | SponsoredTrump’s Secret WeaponWall Street is nervous. Billionaires are shifting assets. And everyday investors? Most are completely unprepa...American Alternative | Sponsored[FREE GIFT] New AI for retail tradersTradeAlgo has found a “backdoor way” for retail traders to profit from the AI arms race by developing its grou...TradeAlgo | SponsoredWarning: Massive IPO Predicted for May 14?The #1 venture capitalist in America predicts that the biggest IPO in history will take place on Wednesday, Ma...Paradigm Press | SponsoredOne Stock Gold Blueprint to Survive the Market ChaosOne Stock Gold Blueprint to Survive the Market Chaos Markets are volatile, uncertainty is everywhere, and A...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRNA Stock Free VRNA Stock Alerts